The CMOS is expected to run for five years

The CMOS is expected to run for five years, with patients to be recruited nationwide via medical centers, prescribing GP’s, and specialists.

Earlier today the specialist contract research organisation Applied Cannabis Research (ACR)—which operates as a division of Southern Cannabis Holdings—announced the official launch of the largest medicinal cannabis study in Australian history.

Applied Cannabis Research will collect data from 20,000 patients nationwide as part of the Cannabinoid Medicine Observational Study (CMOS), with the goal of assessing the safety and efficacy profile of medicinal cannabis products.

Link to the full article:

Applied Cannabis Research Launches Largest Medicinal Cannabis Study in Australian History

Leave a Reply